ATOH1 relevant diseases are treated by suppressing the natural antisense transcript of atonal homolog 1 (ATOH1)

ATOH1 relevant diseases are treated by suppressing the natural antisense transcript of atonal homolog 1 (ATOH1)

  • CN 102,947,451 B
  • Filed: 05/25/2011
  • Issued: 09/22/2017
  • Est. Priority Date: 05/26/2010
  • Status: Active Grant
First Claim
Patent Images

1. at least one ASON for targetting the natural antisense transcript of atonal homolog 1 (ATOH1) polynucleotides existsPrepare the purposes in the function of atonal homolog 1 (ATOH1) polynucleotides and/or the medicine of expression, institute in up-regulation biosystemIt is 10 to 30 nucleotides to state the length of ASON, and the sequence of the natural antisense transcript is selected from SEQ ID NO:

  • 2,The sequence of wherein described at least one ASON is selected from SEQ ID NO;

    4.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×